Scailyte Email Format
Biotechnology ResearchBasel-stadt, Switzerland11-50 Employees
Scailyte is a biotechnology research company headquartered at 35 Lichtstrasse, Basel, Basel-Stadt, Switzerland, with 11-50 employees. It specializes in AI-driven biomarker discovery from single-cell omics data, leveraging its proprietary platform ScaiVision. To date, Scailyte has analyzed more than 60 million single-cell profiles and developed several patent-pending biomarker signatures through its network of clinical partners and access to patient cohorts in oncology and auto-immunity. Headquartered in Basel, Scailyte collaborates with clinical-stage biotech and pharmaceutical companies worldwide to support biomarker-driven drug development. Revenue is reported in the range of $1 million to $10 million, and funding is around $1.8 million.